PARAG SHAH

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ALBANY, NY NPI 1497740864

General Payments — all program years on this page

$1,389.72

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $279.87 across 35 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $279.8735

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $225.1832
Amgen Inc. $20.871
BOSTON SCIENTIFIC CORPORATION $17.271
PFIZER INC. $16.551

By program year

Program yearAmountRecords
2018 $91.517
2019 $190.5730
2020 $39.122
2021 $171.3323
2022 $169.8917
2023 $447.4344
2024 $279.8735

Records — PY2024 (35)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087235577 Novartis Pharmaceuticals Corporation $8.68 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235579 Novartis Pharmaceuticals Corporation $5.39 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235581 Novartis Pharmaceuticals Corporation $4.98 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235597 Novartis Pharmaceuticals Corporation $6.18 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235599 Novartis Pharmaceuticals Corporation $3.16 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235601 Novartis Pharmaceuticals Corporation $5.50 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235603 Novartis Pharmaceuticals Corporation $5.88 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235605 Novartis Pharmaceuticals Corporation $16.27 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235607 Novartis Pharmaceuticals Corporation $2.51 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235609 Novartis Pharmaceuticals Corporation $6.08 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235611 Novartis Pharmaceuticals Corporation $12.08 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235613 Novartis Pharmaceuticals Corporation $3.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235615 Novartis Pharmaceuticals Corporation $3.48 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235617 Novartis Pharmaceuticals Corporation $13.56 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235619 Novartis Pharmaceuticals Corporation $1.94 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235621 Novartis Pharmaceuticals Corporation $11.92 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235623 Novartis Pharmaceuticals Corporation $6.69 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235625 Novartis Pharmaceuticals Corporation $10.71 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235627 Novartis Pharmaceuticals Corporation $2.73 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235629 Novartis Pharmaceuticals Corporation $9.30 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235631 Novartis Pharmaceuticals Corporation $4.28 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235633 Novartis Pharmaceuticals Corporation $4.15 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235635 Novartis Pharmaceuticals Corporation $1.47 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235637 Novartis Pharmaceuticals Corporation $6.03 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235641 Novartis Pharmaceuticals Corporation $6.18 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235643 Novartis Pharmaceuticals Corporation $1.77 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235645 Novartis Pharmaceuticals Corporation $13.44 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235647 Novartis Pharmaceuticals Corporation $10.56 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235649 Novartis Pharmaceuticals Corporation $3.52 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235653 Novartis Pharmaceuticals Corporation $13.97 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235655 Novartis Pharmaceuticals Corporation $7.03 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087235657 Novartis Pharmaceuticals Corporation $12.74 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092296221 Boston Scientific Corporation $17.27 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116106445 Amgen Inc. $20.87 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131891057 PFIZER INC. $16.55 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.